Endothelin receptor antagonism-based treatment for scleroderma renal crisis. | Am J Kidney Dis;62(2): 394-5, 2013 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Endothelin receptor antagonism-based treatment for scleroderma renal crisis.

Izzedine, Hassane; Rouvier, Philippe; Deray, Gilbert.

Am J Kidney Dis ; 62(2): 394-5, 2013 Aug.

Article in En | MEDLINE | ID: mdl-23769136

Subject(s)

Endothelin Receptor Antagonists; Renal Insufficiency, Chronic/drug therapy; Renal Insufficiency, Chronic/etiology; Scleroderma, Systemic/complications; Sulfonamides/therapeutic use; Adult; Bosentan; Female; Humans

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Sulfonamides / Renal Insufficiency, Chronic / Endothelin Receptor Antagonists Limits: Adult / Female / Humans Language: En Journal: Am J Kidney Dis Year: 2013 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Sulfonamides / Renal Insufficiency, Chronic / Endothelin Receptor Antagonists Limits: Adult / Female / Humans Language: En Journal: Am J Kidney Dis Year: 2013 Document type: Article Country of publication: United States